New hope for rare blood disease: gentler transplant trial seeks to replace toxic chemo
NCT ID NCT04784052
Summary
This trial is testing a new way to perform stem cell transplants for people with Fanconi anemia, a rare genetic disorder that causes bone marrow failure. The goal is to use a special, processed donor graft and an experimental antibody called JSP-191 during the pre-transplant conditioning, hoping this leads to successful engraftment with fewer and less severe side effects than standard chemotherapy. Up to 18 participants will be followed for two years to see if this approach is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FANCONI ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
RECRUITINGStanford, California, 94305, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.